Cited by 248Cancer Cells and MetastasisOvarian cancer diagnosis and treatmentCellular Mechanics and Interactions

Compact spheroid formation by ovarian cancer cells is associated with contractile behavior and an invasive phenotype

Sodek, Katharine L., Ringuette, Maurice J., Brown, Theodore J.·2009·International Journal of Cancer

Abstract

Ovarian cancer cells are present in malignant ascites both as individual cells and as multicellular spheroid aggregates. Although spheroid formation affords protection of cancer cells against some chemotherapeutic agents, it has not been established whether a relationship exists between invasive behavior and predisposition to spheroid formation. Aspects of spheroid formation, including cell‐matrix adhesion, remodeling and contractility are characteristic myofibroblast‐like behaviors associated with fibrosis that contribute to tumor growth and dissemination. We explored the possibility that cell behaviors that promote spheroid formation also facilitate invasion. Our analysis of 6 human ovarian cancer cell lines indicated that ovarian cancer cells possessing myofibroblast‐like properties formed compact spheroids and invaded 3D matrices. These cells readily contracted collagen I gels, possessed a spindle‐like morphology, and had elevated expression of genes associated with the TGFβ‐mediated fibrotic response and/or β1 integrin function, including fibronectin (FN), connective tissue growth factor (CTGF/CCN2), lysyl oxidase (LOX1), tissue transglutaminase 2 (TGM2) and urinary plasminogen activator receptor (uPAR). Whereas cell aggregation was induced by TGFβ, and by β1‐integrin overexpression and activation, these treatments did not stimulate the contractile activity required for spheroid compaction. The positive relationship found between compact spheroid formation and invasive behavior implies a preferential survival of an invasive subpopulation of ovarian cancer cells, as cells in spheroids are more resistant to several chemotherapeutics. Preventing the formation of ovarian cancer spheroids may represent a novel strategy to improve the efficacy of existing therapeutics. © 2008 Wiley‐Liss, Inc.

Integrity signals

Registry

Crossref · 10.1002/ijc.24188

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Sodek, K. L., Ringuette, M. J., & Brown, T. J.
Affiliations
Mount Sinai Hospital (CA)
Corresponding author
Brown, Theodore J.
Venue
International Journal of Cancer
Publisher
Wiley
Published
2009-02-24
Volume
124
Issue
9
Pages
2060-2070
ISSN
  • 0020-7136 (ISSN-L)
  • 1097-0215
OpenAlex
W2078354424
Cited by
248
References
62
Citations by year
2026: 5 · 2025: 4 · 2024: 7 · 2023: 17 · 2022: 10 · 2021: 16 · 2020: 28 · 2019: 16 · 2018: 17 · 2017: 26 · 2016: 23 · 2015: 16 · 2014: 18 · 2013: 12 · 2012: 15
FWCI
2.99
Type
journal article
Language
en
Open access
closed
Locations
  • International Journal of Cancer (publishedVersion)
  • PubMed (publishedVersion)
Funders
Ovarian Cancer Research Fund
Topics
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian cancer diagnosis and treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
Keywords
ovarian cancer, multicellular spheroids, tumor invasion, cell contractility, TGF-beta signaling, beta1 integrin, extracellular matrix remodeling, fibrosis, malignant ascites, chemoresistance, connective tissue growth factor, lysyl oxidase, tissue transglutaminase, fibronectin
MeSH terms
Protein Glutamine gamma Glutamyltransferase 2, Cell Adhesion, Cell Movement, Collagen, Extracellular Matrix, Female, Fibroblasts, Fibronectins, Humans, Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase, Neoplasm Invasiveness, Ovarian Neoplasms, Phenotype, Transglutaminases, Tumor Cells, Cultured, Spheroids, Cellular, Integrin beta1, GTP-Binding Proteins, Cell Proliferation, Transforming Growth Factor beta1, Receptors, Urokinase Plasminogen Activator, Connective Tissue Growth Factor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review